Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects
Clinical trial NCT04829786 · COMPLETED
Trial details
- NCT number
- NCT04829786
- Sponsor
- Clementia Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-10-23
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.